Hikma Pharmaceuticals PLC hit a new 52-week high, surpassing its previous peak of £23.14, which the company achieved on ...

PLC (LSE: HIK), a global pharmaceutical company, is set to announce its financial results for the year ending December 31, 2024, on Wednesday, February 26, 2025. The company will make a recording of ...

London – M42, a global health leader powered by artificial intelligence (AI), and Hikma Pharmaceuticals PLC (Hikma), announced the signing of a strategic memorandum of understanding (MOU), to ...

Dubai, United Arab Emirates – Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical group, today announces that it has signed a strategic memorandum of understanding (MOU) with M42, a ...

Shares of Hikma Pharmaceuticals PLC HIK advanced 1.63% to £22.48 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the FTSE 100 Index UKX rising 0. ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

1 Day HKMPY 2.76% DJIA 0.30% S&P 500 0.61% Health Care/Life Sciences -1.75% ...

Recursion Pharmaceuticals has a flashy drug development platform. It has a lot to prove about whether that platform's use of AI is helpful. Some power players have backed it with significant ...

HOUSTON and CAMBRIDGE, Mass., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX), a clinical-stage biopharmaceutical company developing therapies for patients with ...

WEST LAFAYETTE, Ind. — Purdue University, in collaboration with Eli Lilly and Company and Merck & Co. Inc., announced Friday (Jan. 17) the launch of the Young Institute Pharmaceutical Manufacturing ...